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Human  monocytes  are  commonly  deﬁned  and  discriminated  by  the  extent  of their cell  surface  expression
of  CD14  and  CD16,  with  associated  differences  in  function  and  phenotype  related  to  the intensity  of
expression  of  these  markers.  With  increasing  interest  into  the function  and  behaviour  of  monocytes,  it
is  important  to have  a clear  understanding  of how  differing  strategies  of  analysis  can  affect  results  and
how  different  protocols  and  population  backgrounds  can  affect  this  highly  morphogenic  cell type.
Using PBMCs  from  populations  with  differing  ethnicities  and  histories  of  parasite  exposure  we  have
characterized  monocyte  phenotype  based  on  intensity  of CD14  and  CD16  expression.  Using  the  surface
markers  HLA-DR,  CCR2  and  CX3CR1,  we  compared  monocyte  phenotype  between  populations  and  further
assessed  changes  in  monocytes  with  freezing  and  thawing  of PBMCs.
Our results  reveal  that  there  is a progression  of  surface  marker  expression  based  on intensity  of  CD14  or
CD16 expression,  stressing  the  importance  of  careful  gating  of  monocyte  subtypes.  Freezing  and  thawing
of  the PBMCs  has  no effect  generally  on  the monocytes,  although  it does  lead  to  a decrease  in  CD16  and
CX3CR1  expression.  We  show  that  there  are  differences  in  the  monocyte  populations  based  on  ethnicity
and  history  of  exposure  to the  common  parasites  Plasmodium  falciparum  and  Schistosoma  haematobium.
This study  highlights  that blood  monocytes  consist  of  a  continuous  population  of cells,  within  which
the  dominant  phenotype  may  vary  dependent  on  the  background  of  the  study  population.  Comparing
results  from  monocyte  studies  therefore  needs  to be  done  with  great  care,  as  ethnic  background  of donor
population,  gating  strategy  and  processing  of  PBMCs  may  all have  an  effect  on outcome  of  monocyte
phenotype.. Introduction
Peripheral blood monocytes, which represent around 10% of
irculating leukocytes in humans, are recognized as the largest
ool of circulating progenitor cells and form a vital part of the
mmune system [1,2]. The enormous heterogeneity in human
onocyte size, morphology, phagocytic function and cell adhe-
ion was ﬁrst described in 1989 [3] and was quickly followed by
Abbreviations: LPS, lipopolysaccharide; MHC, major histocompatibility com-
lex; PBMC, peripheral blood mononuclear cell; LN2, liquid nitrogen; MFI, mean
uorescence index; FSC, forward scatter; SSC, side scatter; NK, natural killer; ELISA,
nzyme linked immunosorbent assay; SWAP, soluble worm antigen preparation;
NOVA, analysis of variance; DP, double positive; SEM, standard error of mean.
∗ Corresponding author. Tel.: +44 1316507706.
E-mail addresses: l.j.appleby@sms.ed.ac.uk, l.j.appleby-1@sms.ed.ac.uk,
aurajappleby@gmail.com (L.J. Appleby).
1 Current address: Research Council of Zimbabwe, P.O. Box CY 924, Causeway,
arare, Zimbabwe.
165-2478 ©  2013 Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.imlet.2013.03.004
Open access under CC BY license. © 2013 Elsevier B.V. 
multiple attempts to discriminate monocyte subtypes. Recently
new nomenclature was  suggested by an expert panel in Bres-
cia, Italy to deﬁne three subsets according to expression of CD14
and CD16 [4]. The major subset consists of CD14highCD16negative
monocytes (CD14++CD16−), while the CD16 expressing monocytes
are usually divided into a CD14highCD16low (CD14++CD16+) and
a CD14lowCD16high (CD14+CD16++) subset. These groupings can
identify monocytes that differ in surface expression of chemokine
markers, major histocompatibility complex (MHC) class II expres-
sion and in their capacity to produce cytokines and phagocytose
microbial particles [1,5–8]. However, while there have been some
in-depth genetic and proteomic analyses of monocyte functions
and cell markers [1,6,9], there is still no universally accepted
demarcation of these subsets based on phenotypic markers [9]. Fur-
thermore, there is no visible clustering of the cell subsets based
Open access under CC BY license. on the CD14 and CD16 surface markers, instead the two mark-
ers form a spectrum of expression levels potentially contributing
to variation between experiments [4,7,10]. Differential expres-
sion of chemokine and scavenger receptors indicates a functional
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Table 1
Study cohorts and description.
Study Donor ethnicity Origin (urban/rural) N
Whole monocyte phenotype African (Zimbabwe) Rural 62
Effects  of cryopreservation on monocyte phenotype African (other) Urban 5
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Effects of genetics or exposure on monocyte phenotype Eu
Afr
otential in terms of trafﬁcking to sites of infection and inﬂamma-
ion. Indeed, monocyte migration and trafﬁcking has been observed
o vary between subsets based on expression of CCR2 and CX3CR1
11]. Another feature of monocytes is their ubiquitous expression
f the MHC  class II surface receptor, HLA-DR, which is frequently
sed to distinguish between CD16 expressing monocytes and CD16
xpressing NK cells [12]. As a receptor that is involved in antigen
resentation [9], it is often considered an activation marker [13–15]
nd indicates functional differences for the monocyte subsets as
ell as subset activation status [12].
Thus far, the majority of human monocyte studies have taken
lace using volunteers of Caucasian background and in high income
ountries where pathologies arising from non-communicable dis-
ases such as atherosclerosis, liver cirrhosis and asthma dominate
16]. This means that, despite the demonstration of the impor-
ance of monocytes in experimental models of parasitic diseases
2,17,18], comparatively little is known about the nature, pheno-
ype and development of monocytes in people exposed to tropical
nfectious diseases. Furthermore the majority of studies investi-
ating monocyte phenotype and function use whole blood or fresh
BMCs rather than cryopreserved peripheral blood mononuclear
ells (PBMCs). Cryopreservation of PBMCs is an indispensable tool
or longitudinal clinical studies as well as during ﬁeldwork when
amples have to be stored and transported from the collection
oint to a laboratory. Furthermore, the capability to retrospectively
nalyze specimens from the same patient allows analysis of large
ample populations, monitoring of clinical status over time or after
reatment and improves accuracy while reducing within-patient as
ell as interassay variability [19,20]. To date, studies determining
he effects of cryopreservation on PBMCs have focused on cell com-
artment changes [21] or maturation pathways [22], but no studies
ave been conducted on the effects of cryopreservation on the cell
henotype which is central to the function of the monocytes.
In this study our aims were (1) to determine changes in expres-
ion levels of cell surface markers occurring within the monocyte
ell population dependent on CD14 and CD16 expression inten-
ity, (2) to assess the stability of these markers during processes
nvolved in freezing and storage, and ﬁnally, (3) to determine if dif-
erences occur in the proportion and phenotype of monocytes in the
ifferent sub-populations between Caucasian individuals who have
een exposed to a typical western lifestyle, and African individuals
ho are lifelong residents of a rural helminth endemic area.
. Methods
.1. Ethical statement
Written consent was obtained from all participants or their
uardians prior to enrolling in the study. Local ethical approval
as given and local review board guidelines adhered to. The cohort
f rural Africans was part of a larger study investigating the epi-
emiology and immunology of human schistosomiasis that was
onducted in the Mashonaland East Province of Zimbabwe. Per-
ission to conduct the study in the region was  obtained from
he Provincial Medical Director. Institutional and ethical approval
as received from the University of Zimbabwe and the Medicaln 4
Urban 21
Zimbabwe) Rural 21
Research Council of Zimbabwe respectively. At the beginning of
the study, parents and guardians of participating children had the
aims and procedures of the project explained fully in the local lan-
guage, Shona, and written consent was obtained from participants’
parents/guardian before enrolment into the study. After collection
of all samples, all participants and their parents/guardians were
offered anthelmintic treatment with the recommended dose of
praziquantel (40 mg/kg of body weight).
2.2. Study populations
To address the different questions, three different cohorts were
used, which are described in Table 1. For the purposes of phen-
otyping monocytes for cell surface expression patterns of the
markers CCR2, CX3CR1 and HLA-DR, a cohort of 62 individuals liv-
ing in a rural area where Schistosoma haematobium is prevalent
was used. All participants were from the Murehwa district in north
eastern Zimbabwe. All individuals recruited into each study were
S. haematobium and co-infection negative and had never received
anti-helminthic treatment. In addition there is little or no infection
with Schistosoma mansoni, soil transmitted helminths and malaria
transmission is sporadic and seasonal [23]. The residents of the area
are subsistence farmers with frequent contact with infected water
for purposes of irrigation, bathing, washing and collecting water
(assessed by questionnaire) [24].
In order to investigate the effects of cryopreservation on mono-
cyte phenotype and cell numbers, peripheral blood from nine
African or Caucasian volunteers, currently living in urban envi-
ronments, was used to compare monocytes from freshly isolated
PBMCs to those from cryopreserved PBMCs. For evaluation of differ-
ences that genetics and lifetime exposure to infection may have on
monocyte phenotype, PBMCs from 21 Africans who  were exposed
to, but negative for, helminth, malaria and HIV co-infections were
compared to 21 age and sex matched Caucasians with no reported
exposure to these pathogens. Table 2 shows the ages (mean, median
and range) of each of the populations (rural African and Caucasian)
used in background comparisons. In order to check for effects of
genetic background vs pathogen exposure, ﬁve donors of African
origin (Kenya (n = 4) and Zimbabwe (n = 1)) were recruited to the
study. All ﬁve donors had grown up in an urban environment.
2.3. Parasitology
Parasite infection status was determined in the Zimbabwean
participants through examination of at least 2 stool and 2 urine
samples collected on 3 consecutive days and a single blood sam-
ple. The urine samples were used for microscopic diagnosis of S.
haematobium infection using the standard urine ﬁltration method
[25], while the stool sample was  used for microscopic diagnosis of
intestinal helminths and S. mansoni infection using the Kato–Katz
method [26]. Blood smears were microscopically examined for
 . Plasmodium falciparum infection, and results conﬁrmed using the
rapid Paracheck test, (Orchid Biomedical Systems, Goa, India) and
serologically tested for HIV status using the DoubleCheckGoldTM
HIV1&2 test kit (Orgenics, Ltd., Yavne Israel). All Zimbabwean
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Table 2
Age of rural African and Caucasian cohorts.
Rural African Caucasian
N Mean Median Range (min–max) N Mean Median Range (min–max)
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Total  21 28.8 28 15–55
onors were selected to be S. haematobium,  S. mansoni, soil trans-
itted helminth, malaria and HIV negative.
.4. Blood collection and isolation of PBMC
Approximately 30 ml  of venous blood was collected in hep-
rinised tubes from all donors. PBMC were isolated through density
entrifugation using LymphoprepTM (Axis-Shield, Cambridgeshire,
K). Heparinised plasma was collected and stored at −80 ◦C until
ssay. PBMCs were counted and resuspended at approximately
 × 107 c/ml in freezing media (90%DMSO, 10%FCS) for cryopreser-
ation and immediately cooled to −80 ◦C in a freezing container
Nalgene Nunc, International) prior to placing in liquid nitro-
en (LN2) until assay. For analysis of fresh PBMCs a further
 ml  of venous blood was collected from each individual on the
ay of thawing and processing cryopreserved samples. The time
etween processing PBMCs for cryopreservation and processing
BMCs for a fresh analysis was no more than a month in any
ase. Processing was performed in the manner described and cells
ere suspended at 5 × 106 cells/ml. Surface staining was  performed
traight away in the same manner as for cryopreserved cells as
escribed.
.5. Phenotyping of monocytes
Cryopreserved PBMCs were thawed straight from LN2 in a 37 ◦C
ater bath until only a small crystal remained. The contents of
he vial were slowly added to complete media (RPMI 1640), sup-
lemented with 10% heat inactivated FCS, 2 mM l-glutamine and
00 U penicillin/streptomycin (all Lonza, Verviers, Belgium). Cells
ere washed twice with complete media, counted in trypan blue
Sigma–Aldrich, Dorset, UK). Cells were washed in PBS (Lonza,
erviers, Belgium) and resuspended at 5 × 105 cells per stain for
ach staining panel.
Fresh and thawed cells for staining were incubated with 10%
CS at 4 ◦C for 10 minutes prior to staining and stained with
lexa488-conjugated anti-CD14 (clone M5E2), PE-Cy7-conjugated
LA-DR (clone L243; all from BD Biosciences, San Jose, CA), Paciﬁc
lue-conjugated CD16 (clone CB16; eBiosciences, San Diego, CA),
lexa647-conjugated CX3CR1 (clone 2A9-1; BioLegend, San Diego,
A), PerCP-conjugated CCR2 (clone 48607; RnD Systems, Min-
eapolis, MN)  or the relevant isotype control for 30 min  at 4 ◦C.
nbound antibodies were washed off and cells were resuspended
n PBS prior to acquisition of at least 50,000 live events on a BD
ACS LSR II (BD Biosciences, San Jose, CA). Compensation was  per-
ormed prior to acquisition of each experiment using BD FacsComp
eads (BD Biosciences, San Jose, CA). Analysis was performed using
lowJo software (TreeStar, USA) and Mean ﬂuorescence index (MFI)
as calculated for each marker with the relevant isotype control
ubtracted.
.6. Monocyte discriminationTo ensure that only CD14+ cells representing monocytes were
nalyzed, a gating strategy was employed to gate only HLA-DR,
D14 expressing cells. Brieﬂy a live gate, to include all leukocytes,
as drawn based on forward scatter (FSC) and side scatter (SSC).10 33.6 31 26–53
11 33 29 25–54
21 33.3 30 25–54
HLA-DR positive cells were gated to exclude any CD16+ natural
killer (NK) cells and other non-MHC expressing cells [12], and true
monocytes were gated based on expression of CD14 and CD16 sur-
face markers.
2.7. Determination of exposure to P. falciparum and S.
haematobium
In order to determine if any arising differences between the
Caucasian and African participants were due to undetected schis-
tosome or Plasmodium parasite infection (current or previous) or
parasite-unrelated mechanisms such as genetic differences, sero-
logical assays were conducted to determine parasite exposure
history. Enzyme linked immunosorbent assay (ELISA) was used
to measure antigen-speciﬁc antibodies to malaria schizont (IgG
and IgM) and schistosome adult worm (IgG4, IgM, IgE) in the
serum. Lyophilized soluble S. haematobium adult worms  (SWAP)
was obtained from the Theodor Bilharz Institute (Giza, Egypt)
and reconstituted as recommended by the manufacturer. Schizont
extract was a kind gift from David Cavanagh (University of Edin-
burgh, UK). ELISAs were performed as reported elsewhere [27,28],
and all ELISAs were performed in duplicate on the same day with
positive and negative controls on each plate.
2.8. Statistical analysis
All statistical analyses were conducted using the statistical
package SPSS version 19. Parametric tests were used when assump-
tions of parametric tests were met, otherwise non-parametric
tests were used [29]. When using parametric tests data were
transformed using appropriate transformations: surface marker
expression (measured as MFI) was  log transformed (log10(x + 1)),
proportions of subsets were arcsine square root transformed, and
antibody responses were square root transformed. In parametric
models age was taken as a continuous variable, sex (male/female)
and donor ethnicity (African/Caucasian) were categorical.
To test the hypothesis that the whole monocyte population is
composed of a continuum of ‘subsets’ consisting of distinct phe-
notypic proﬁles, differences in expression of surface markers were
analyzed using a one way  analysis of variance (ANOVA) with subset
as a grouping variable and post hoc tests used to determine sig-
niﬁcant differences between adjacent subsets. Differences in the
proportion of each subset were analyzed using an arcsine square
root transformation and a one way  ANOVA using type I sequential
sums of squares in a similar manner as discussed. When sample
size and assumptions did not allow, the Kruskal–Wallis test was
used to test for differences between surface marker expression and
subset proportion.
In order to investigate the effects of cryopreservation on mono-
cyte phenotype with respect to changes in proportions of subsets
and expression of phenotypic markers, the Wilcoxon Signed Ranks
Test was  used with processing method (fresh PBMCs vs. cryopreser-
ved PBMCs) as grouping variable. Differences in intensity of surface
marker expression between subsets were determined by MANOVA,
allowing for sex and age using type I sequential sums of squares.
The effects of exposure history to parasitic infection on mono-
cyte subsets were tested by ANOVA, allowing for sex (categorical)
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Fig. 1. Representative ﬂow cytometry dot plots demonstrating the gating strategy employed to deﬁne CD14+ monocytes. (A) Live gate for total leukocytes based on the
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oorward scatter (FSC) and side scatter (SSC) properties, (B) separation of monocytes f
ased on CD14 and CD16 expression.
nd age (continuous) using type I sequential sums of squares. Dif-
erences in positive antibody responses to parasite antigen between
opulations were tested using the Chi-squared test for associa-
ion after categorizing responses into positive (OD > 0) or negative
OD = 0). Signiﬁcant p values are reported as p ≤ 0.05 unless other-
ise indicated.
. Results
.1. Discrimination of MHC  II positive monocytes
Monocytes represent a population of MHCII cells that express
arying levels of both CD14 and CD16 surface markers. Fig. 1 illus-
rates the gating strategy used that excludes non-MHCII, CD16
ositive NK cells, but includes HLA-DR and CD14 positive mono-
ytes. The commonly observed ‘banana’ shape that is seen with this
ell population and the lack of clustering within the double positive
opulation is demonstrated in Fig. 1C.
ig. 2. Examples of previously published gating strategies using the same representative
D16  positive and CD16 negative monocytes, and (B) the phenotypic proﬁle associated
ubsets,  regCD14, DP and regCD16 based on CD14 and CD16 expression, and (D) the ass
ne-way ANOVA. Signiﬁcant differences are indicated with * (p < 0.05) or ** (p < 0.001).on HLA-DR expressing CD14 expressing NK cells prior to (C) gating total monocytes
3.2. Different gating strategies give different phenotypic proﬁle
patterns
There is currently no consensus on the best gating strategy of
monocytes with at least three different methods published that
involve not only different markers of deﬁnition [4,30,31] but also
different numbers of subsets [32–34]. Thus we investigated if there
were differences in the basic phenotypic characteristics of mono-
cytes based on different gating strategies according to CD14 and
CD16 MFI. We  found stark differences in subset expression of
surface markers while employing different gating strategies as
demonstrated in Fig. 2. In sub-setting the monocytes into two
groups (Fig. 2 upper panels) there is an obvious difference in pat-
terns of expression in comparison to three groupings (Fig. 2, lower
panels). Expression of the phenotypic markers CX3CR1 and HLA-
DR is observed to be higher in the middle double positive (DP)
(CD14++CD16+) monocytes than in the CD16 monocytes; a dif-
ference which is lost in the two  subset strategy. Due to a lack of
clariﬁcation in the literature about the discrimination of the DP
monocytes, we were interested in determining if the DP expressing
 donor as in Fig. 1. Top panel demonstrating (A) the two gating strategy based on
 with the two  subsets. Lower panel demonstrates (C) the gating strategy of three
ociated surface marker expression proﬁle. Signiﬁcant p values are from a post hoc
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Fig. 3. Division of monocyte population into ﬁve subsets with varying levels of expression of CD14 and CD16. (A) Representative dot plots demonstrating the division of
the  ﬁve subsets to include the traditional CD14++CD16− (regCD14), CD14+CD16++ (regCD16) and three subsets within the CD14 CD16 double positive population: dpCD14,
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(LADRhi, dpCD16. (B) Pie chart illustrating the proportions, mean and (SEM) of the
frican  population of different monocyte phenotypic surface markers within each
LA-DR, (D) CCR2 (E) CX3CR1. Signiﬁcant p values are from a post hoc one-way AN
ubpopulation of monocytes was a subset phenotypically distinct
rom both the CD14++CD16− and the CD14+CD16++ monocyte
opulations. Based on expression of HLA-DR [12], we divided this
iddle population into three separate subsets to give a double pos-
tive CD14high population (dpCD14), a double positive CD16high
opulation (dpCD16) and a double positive HLA-DR high popula-
ion (HLADRhi) (Fig. 3A). The HLADRhi designation was based on
his group expressing the highest levels of HLA-DR (Fig. 3C). Gat-
ng in such a manner would identify any differences occurring both
ithin this group, as well as between this group and the adjacent
ubsets. For the purposes of this manuscript we wished to main-
ain a distinction between what has been previously published and
greed to (three subsets deﬁned as CD14++CD16−,  CD14++CD16+
nd CD14+CD16++) and the monocyte groupings as we deﬁned
hem here. We  thus decided to designate the CD14++CD16−  as
egCD14 monocytes and the CD14+CD16++ as regCD16 monocytes.
he gating of all ﬁve subsets is shown in Fig. 3A with the proportions
f each of the subsets illustrated in Fig. 3B.
.3. Rather than distinct subsets, the monocyte gate consists a
pectrum of progressively changing phenotypic markers
From the larger cohort of 62 Africans we analyzed the ﬁve mono-
yte groupings with respect to changes in their surface expression
f the phenotypic markers CCR2 and CX3CR1, and the MHC  recep-
or HLA-DR. Fig. 3C–E shows the mean expression levels of these
arkers in each of the monocyte groupings. The signiﬁcantly
levated level of HLA-DR in the HLADRhi subset compared to
pCD16 (p < 0.001) and the regCD14 cells (p < 0.001) may  indi-
ate an increased activation status in these cells (Fig. 3C). CCR2
hows a spectrum of expression levels with the highest on the
egCD14 monocytes, decreasing with increasing CD16 expression
Fig. 3D). The CD14high expressing monocytes (regCD14, dpCD14ubsets seen in the rural African population (n = 62). (C)–(E) Mean MFI  for the rural
e ﬁve subsets: 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: regCD16. (C)
igniﬁcant differences are indicated with * (p < 0.05) or ** (p < 0.001).
and HLADRhi) do not show signiﬁcant differences in CCR2 expres-
sion, however with increasing CD16 expression (transitioning
the subset from regCD14 towards regCD16) there is a concur-
rent decrease in CCR2 expression (from HLADRhi to dpCD16: MFI
difference = −55.48, p = 0.001, and from dpCD16 to regCD16 MFI
difference = −63.68, p < 0.001). In contrast, CX3CR1 shows signiﬁ-
cant differences in expression level across all subsets (Fig. 3E), with
the lowest expression of CX3CR1 on CD14++ monocytes (regCD14
and dpCD14) as previously reported [35]. Interestingly, the high-
est expression is in the dpCD16 monocytes with a signiﬁcant
decrease in expression between dpCD16 and regCD16 mono-
cytes (dpCD16 to regCD16 MFI  difference = −14,414, p < 0.001)
(Fig. 3E). The regCD16 monocytes show a signiﬁcant decrease in
marker expression compared to dpCD16 for all analyzed markers
(Fig. 3C–E).
3.4. Total monocyte number but not subset proportion differs
between fresh and cryopreserved PBMCs
To investigate whether monocytes change their expression lev-
els and phenotype dependent on cryopreservation, nine donors
of Caucasian or African descent, with predominantly urban back-
grounds, had a collection of peripheral blood for PBMC puriﬁcation
and cryopreservation. In a second blood draw, fresh PBMCs were
puriﬁed, and these were stained on the same day as their cryo-
preserved cells. Cryopreserved cells show a greater proportion of
monocytes as a percentage of live gated cells, as shown in Fig. 4A
(z = −2.67, p = 0.004). However there were no signiﬁcant differences
in the proportion of subsets as tested by one-way ANOVA and
repeated measures as shown in Fig. 4B. Differences in cell surface
expression between fresh and cryopreserved monocytes are indi-
cated in Fig. 5. No differences are seen in CD14, HLA-DR or CCR2
expression (Fig. 5A, C and D), but signiﬁcant differences are seen in
L.J. Appleby et al. / Immunology
Fig. 4. Differences between fresh and cryopreserved PBMCs from 9 individuals with
an  urban background (African: n = 5; Caucasian: n = 4) were compared. (A) Fresh and
cryopreserved monocytes as frequency of live gated population. Monocytes from
fresh PBMCs show a signiﬁcantly smaller proportions of monocytes in comparison
to cryopreserved PBMCs, measured non-parametrically with Wilcoxon Signed Ranks
Test (z = −2.67, p = 0.004). (B) Mean and SEM of proportions of the ﬁve subsets in fresh
and cryopreserved preparations. 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5:
regCD16. Open bars: fresh PBMCs; closed bars: cryopreserved PBMCs. There are no
signiﬁcant differences in proportions dependant on preparation method (measured
non-parametrically using the Wilcoxon signed ranks test).
Fig. 5. Differences observed in cell surface phenotype between fresh (open bar, n = 9) a
HLA-DR, (D) CCR2 and (E) CX3CR1. 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: re
rank  test and are indicated with *. Letters 152 (2013) 32– 41 37
almost all subsets for CD16 and CX3CR1 surface expression (Fig. 5B
and E, respectively), with fresh PBMCs showing a higher MFI  for all
subsets in both markers.
3.5. African and Caucasian donors show differences in
proportions of monocyte subsets
As the majority of studies investigating monocytes have taken
place in high income areas, we were interested in whether the
phenotypic patterns we have characterized were a feature of the
study population or if they can be transferred across populations.
We therefore undertook an investigation to phenotype mono-
cytes from donors of different ethnicities. Fig. 6A–C illustrates
the differences seen in ﬂow analysis between (A) rural African
monocytes (B) urban African monocytes and (C) Caucasian mono-
cytes. There is a stark difference in the proportion of CD16 and
CD14 expressing subsets between the ethnicities. Fig. 6D shows
the proportions of the ﬁve subsets in the whole African and Cau-
casian populations that we  sampled. Caucasians are exhibiting a
signiﬁcantly greater proportion of regCD14 cells compared to rural
Africans (Fig. 6D, 1), while monocytes from Africans have a sig-
niﬁcantly greater proportion of all other subsets except dpCD14
(Fig. 6D, 2–5). Fig. 7 shows the differences in expression levels of
surface markers between these subsets for the rural African and
Caucasian groups. Interestingly, while the surface marker MFIs
between the two populations are not always similar, they follow
the same pattern of expression for all subsets. The surface expres-
sion of the activation marker HLA-DR is higher on the rural African
population, predominantly in the CD14high monocytes (Fig. 7A).
Similarly, CCR2 is signiﬁcantly higher on rural African monocytes
in the regCD14 and dpCD14 groups (Fig. 7B). The expression of the
chemokine and adhesion receptor CX3CR1 is higher in the Cau-
casian cohort, although this is only signiﬁcant in the dpCD14 subset
(Fig. 7C).
nd cryopreserved (closed bar, n = 9) preparations of cells. (A) CD14, (B) CD16, (C)
gCD16. Signiﬁcant differences (p < 0.05) are from nonparametric Wilcoxon signed
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Fig. 6. Top Panel (A)–(C) representative CD14/CD16 dot plots of monocytes from (A) a rural African donor, (B) an urban African donor and (C) a Caucasian donor. Cells are
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fricans (n = 21, ﬁlled bars), Africans from urban environments (n = 5, grey bars) a
egCD16. P values are from the Mann–Whitney test with an applied Bonferonni cor
.6. Caucasians and rural Africans demonstrate different histories
f parasite exposureIn order to understand whether the observed differences in
ubset proportions between the different populations are due to
istory of exposure to parasitic exposure, we were interested
n antibody responses to both P. falciparum and S. haematobium
ig. 7. Mean expression levels of surface markers between rural Africans (closed bars, 
LA-DR, (B) CCR2, (C) CX3CR1. 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5: regCD
*  (p ≤ 0.001).g the differences in mean and SEM of monocyte subset proportions between rural
ucasians (n = 21, open bars). 1: regCD14; 2: dpCD14; 3: HLADRhi; 4: dpCD16; 5:
n. Signiﬁcant p values (p < 0.0167) are indicated with *.
antigens. Fig. 8 shows the antibody responses to P. falciparum sch-
izont antigens (upper panels A and B) and SWAP (lower panels C and
D). There was  very little IgM antibody response to malaria schizont
in either the rural African or Caucasian populations, indicating that
neither group had recent exposure to the parasite (Fig. 8A). In con-
trast, the rural Africans had a greater IgG response to the schizont
antigen in comparison to the Caucasians (F = 8.042, p = 0.009), as
n = 21) and Caucasians (open bars, n = 21) based on surface marker by subset. (A)
16. Signiﬁcant p values from Mann Whitney test are represented by * (p ≤ 0.05) and
L.J. Appleby et al. / Immunology Letters 152 (2013) 32– 41 39
Fig. 8. Antibody responses of rural Africans (closed circles, n = 15) and Caucasians (open squares, n = 16) to parasite antigens. (A) IgM and (B) IgG response to malaria schizont.
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ith  * (p < 0.05).
vidence of previous exposure (Fig. 8B) [36,37]. IgM against SWAP
s associated with recent exposure to schistosomiasis, and both
opulations showed low levels of SWAP speciﬁc IgM, although the
ural African population shows slightly elevated levels in compar-
son to the Caucasians (Fig. 8C) (mean OD = 0.579, Standard error
f mean (SEM) = 0.021 and mean OD = 0.497, SEM = 0.033 respec-
ively). As both groups are negative for schistosomiasis deﬁned
y egg count in urine, the low IgM response is not surprising. IgE
gainst SWAP is associated with cumulative history of exposure
o the parasite antigen. Fig. 8D shows that there is no signiﬁcant
ifference between the rural African and Caucasian populations
ith regards to IgE responses (F = 3.684, p = 0.066). However the
umber of IgE positive responders to SWAP in the African group is
igniﬁcantly greater than the number of IgE positive responders to
WAP in the Caucasian group (80% and 37.5% positive responders
espectively; 2 (2) = 5.743, p = 0.017). Taken together this indicates
hat while neither population is demonstrating current exposure
o either plasmodium or schistosome parasite infection, the rural
fricans have had more history of exposure to the schistosome
dult worm and are showing signs of developing immunity to the
arasite.
. Discussion
In humans, the three identiﬁed monocyte subsets have dif-
ering migration, maturation and functional potential [4,35], and
here have been reports of an increase in the CD14+CD16++ sub-
et in numerous pathologies [5,8,38–40], however the deﬁnition
f CD14+CD16++ monocytes varies within each of these studies.
y dividing the monocytes into ﬁve separate subsets, we have
emonstrated that the CD14++CD16+ subset is made up of a phe-
otype with signiﬁcant variation in the expression levels of typical
arkers. The decision to subdivide what is commonly known as
he CD14++CD16+ subset was based on inconsistency within theA. Signiﬁcant p-values are from Type I sequential sums of squares and are indicated
ﬁeld as to where this division lay, combined with the observa-
tion that HLA-DR is expressed most highly by what we deﬁned
as the HLADRhi subset [9,12]. As HLA-DR is an activation marker
[41,42] this may  indicate a functional role for these monocytes
that is not shared by either of the dpCD14 or dpCD16 monocytes.
This method of division of the middle CD14+CD16++ monocyte
population gives a clear indication that there is a progressive
pathway between the monocyte subsets. This continuum may
not be surprising considering recent murine data demonstrating
that the Ly6C+ monocytes (correlate of human CD14++CD16+ and
CD14++CD16− monocytes) are precursors of Ly6C− monocytes
(correlate of human CD14+CD16++) [43].
CCR2 and CX3CR1 are chemokine receptors that have frequently
been reported to have disparate afﬁliations with monocyte subsets
[3,35]. Here we report no signiﬁcant differences in CCR2 expression
within CD14++ expressing subsets, with signiﬁcant differences in
expression only occurring with the onset of CD16 expression. In
contrast CX3CR1 expression shows a clear distinction in expression
levels within each of the ﬁve subsets and differential expres-
sion between the dpCD16 and regCD16 monocytes. As CX3CR1
is involved in adhesion to the blood vessel wall and with rapid
extravasation of the cell [11], this may  be indicative of a separate
function for the regCD16 (CX3CR1low) monocytes and the dpCD16
(CX3CR1high) monocytes. Indeed the regCD16 subset consistently
shows signiﬁcant decreases in surface marker expression to the
dpCD16 subset.
Due to time or physical restrictions, as well as for longitudinal
cohort studies, many research protocols including our own require
cryopreservation of PBMCs before processing and staining for ﬂow
cytometry. Therefore we investigated whether there were changes
in these deﬁned ﬁve subsets based on processing of the cells. We
show that total monocyte numbers were reduced following cryo-
preservation. However, there were no signiﬁcant differences in the
proportions of each of the subsets. The MFI of CD14 and CD16
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ere examined, in particular as the MFI  of CD16 has been reported
o be upregulated with activation [44,45]. The CD16 receptor was
xpressed to a higher intensity on fresh than cryopreserved cells.
imilarly CX3CR1 showed a signiﬁcantly higher MFI  in each sub-
et for the fresh PMBCs. These differences may  be a consequence
f the freezing process, perhaps inﬂuencing the stability of these
arkers and preventing a rapid activation of the thawed cells in
he same manner as the fresh preparation. Previous studies have
ound no differences in frozen and fresh PBMCs with regards to T
ell proportion and function [46] as well as macrophage differenti-
tion [22]. Here we have found that while the MFI  between the two
reparations can alter, the patterns remain robust, indicating that
hile the two methods are comparable they should not be used to
ee within experiment differences.
For any study evaluating interventions that may  alter blood
onocytes, it is important to know if genetic and environmental
ackground differences between individuals impact on monocyte
ubset balance. We  show here that such differences do exist in
fricans and Caucasians, with Africans exhibiting a greater pro-
ortion of CD16 expressing subsets compared to Caucasians. All
ndividuals were negative for helminth infections, malaria and
IV. However, the rural African population did show evidence of
ast exposure to malaria and schistosomiasis infection. In many
athologies frequently occurring in urban environments, such
s asthma, microbial infection and arthritis, there is a reported
ncrease in the CD14++CD16+ and CD14+CD16++ subsets, which
ay  be indicative of an activated immune system [8,38,39].
nowledge of these baseline subset differences is important for
ndertaking studies in environments where exposure to numerous
athogens is common, as changes seen with other infections may
ot be as distinct. Interestingly, the pattern of monocyte subsets in
he African group living in a western environment lay between the
aucasians and the rural Africans exposed to schistosomiasis. This
ndicates that the differences seen in the subset patterns may  be
ore of a function of exposure to parasites than genetics. However,
his group of individuals was small, and only one was  originally
rom Zimbabwe, where the rural Africans originated from. There is
eportedly more human genetic diversity within Africa than in the
est of the world so these differences could be as much to do with
enetic differences between the populations as with the exposure
istory [47]. In terms of differences in phenotype of the mono-
yte subsets, similar to the preparations of the cells, the pattern
f expression of the subset markers remained the same between
he different ethnicities. Previous reports have shown that CCR2 is
ow to negative on CD16 expressing monocytes [31], whereas our
roup, in studying PBMCs isolated from individuals in Zimbabwe,
as always found evidence of a certain expression level of this
arker (unpublished data). We  show here that the PBMCs from
ural Africans express CCR2 to a greater intensity in comparison to
aucasians, particularly in the CD14 expressing monocytes. Over-
ll, expression of HLA-DR was higher in the rural African population
han in Caucasians. As an activation marker that is rapidly upregu-
ated with infection, the HLA-DR expression level may  be indicating
ecent exposure to infection or, perhaps an impaired ability to shed
LA-DR into the serum in response to inﬂammation [13,14,48].
X3CR1 showed a tendency towards higher expression in Cau-
asian monocytes similar to CD16 expression (data not shown) and
s in agreement with the differences in CD16 observed with prepa-
ation differences. Previously reported associations between CD16
nd CX3CR1, as well as with CD14 and CCR2, make it unsurpris-
ng that the signiﬁcant differences are seen in the same direction
etween these markers within these populations. Taken together
t is clear that while monocyte subset markers do not change pat-
ern between different populations, the expression levels, as well
s proportions of subsets can be signiﬁcantly different. This may  be
ue to a lifetime of exposure to pathogens, such as malaria and Letters 152 (2013) 32– 41
schistosomiasis, and the immune response associated with this
exposure. Whilst the sample size reported on is small, the ﬁndings
do highlight the importance of taking care when comparing results
from different experiments, or in recruiting individuals into a study.
Further research into differences in monocyte subsets based on eth-
nic background would be valuable in fully understanding the extent
of these differences.
5. Conclusions
In this study we present data demonstrating the spectrum of
maker expression within the recently deﬁned subsets of human
monocytes [4]. With direct relevance to research in the ﬁeld we
show that there are few changes in these subsets or expression
of surface markers in response to cryopreservation. We  also show
that expression levels of typical markers for monocyte function
do change in intensity based on ethnic background of the individ-
ual. While the scope of this study does not allow for determining
what drives these changes, it does emphasize the important role
monocytes have in exposure to disease.
Our study focused on surface marker expression, but it will be
interesting to assess differences in intracellular markers, cytokine
secretion and particularly functional capabilities within these ﬁve
subsets. Whilst sorting the cells in large enough quantities for func-
tional analysis may  be a challenge, using this monocyte gating
technique we have shown that there is a shifting spectrum of phe-
notypic markers that may  lead to clues as to the function of each of
the monocyte subsets. Importantly our study indicates that confor-
mity across research groups in gating of these subsets is necessary
in order to compare studies.
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